Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 27 holding rows worth $329,167,000.

Accession
0001085146-22-003129
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 27 entries on the cover page, a total value of $329,167,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $329,167,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM1,240,932$180,816,000thousands by filing date
QUIDELORTHO CORP COM219798105Stock499,263$48,518,000thousands by filing date
OPKO HEALTH INC68375N103COM7,252,756$18,349,000thousands by filing date
MODERNA INC60770K107COM89,700$12,814,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM175,000$11,748,000thousands by filing date
AGENUS INC00847G705COM NEW4,656,132$9,033,000thousands by filing date
SEMA4 HOLDINGS CORP81663L101COM6,585,354$8,298,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock603,994$6,390,000thousands by filing date
CONTRAFECT CORP212326300COM1,969,222$6,046,000thousands by filing date
FORIAN INC34630N106cs1,333,477$5,854,000thousands by filing date
PROSHARES TR74347X831ULTRAPRO QQQ150,000$3,600,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock803,845$3,553,000thousands by filing date
IMMUTEP LTD45257L108SPONSORED ADS1,557,325$3,161,000thousands by filing date
Accelerate Diagnostics00430H102COM2,445,791$2,428,000thousands by filing date
Pfizer Inc.717081103COM500,000$1,513,000thousands by filing datecall
DERMTECH INC24984K105COM246,569$1,366,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM463,998$1,336,000thousands by filing date
POINT BIOPHARMA GLOBAL INC730541109COM129,810$884,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM60,600$753,000thousands by filing datecall
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock350,000$656,000thousands by filing datecall
VERTEX ENERGY INC92534K107COM56,800$598,000thousands by filing date
BIOGEN INC COM09062X103Stock2,412$492,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM728,100$428,000thousands by filing date
SOLENO THERAPEUTIVS, INC.834203200COMM2,132,000$394,000thousands by filing date
VERTEX ENERGY INC92534K107COM150,300$49,000thousands by filing datecall
ACADIA PHARMACEUTICALS INC004225108COM300,000$48,000thousands by filing datecall
VELO3D INC92259N104COM30,379$42,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-22-003129this filing2022-08-15acceptance time not in the bulk data set